![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
1. 13522-16-2
2. 2,16-dipiperidin-1-ylandrosta-3,17-diol
3. (2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-10,13-dimethyl-2,16-di(piperidin-1-yl)hexadecahydro-1h-cyclopenta[a]phenanthrene-3,17-diol
4. (2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-10,13-dimethyl-2,16-di(piperidin-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,17-diol
5. 2,16-dipiperidin-1-yl-androsta-3,17-diol
6. Einecs 236-866-3
7. Schembl11134468
8. Dtxsid80928910
9. Mfcd09952333
10. Akos015917781
11. Zinc118912521
12. Ds-16146
13. Cs-0086285
14. 2,16-di(piperidin-1-yl)androstane-3,17-diol
15. 522d162
16. 2beta,16beta-di(1-piperidinyl)-5alpha-androstane-3alpha,17beta-diol
17. (8r,9s,10s,13s,14s)-10,13-dimethyl-2,16-di(piperidin-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,17-diol
Molecular Weight | 458.7 g/mol |
---|---|
Molecular Formula | C29H50N2O2 |
XLogP3 | 5.4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 458.38722884 g/mol |
Monoisotopic Mass | 458.38722884 g/mol |
Topological Polar Surface Area | 46.9 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 704 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |